We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Urine Test Ensures Asthmatic Children Receive Appropriate Treatment

By LabMedica International staff writers
Posted on 14 Dec 2014
Print article
Image: Gross pathology of a cross section of a lung from an asthmatic with obstruction of major airways or bronchi (Photo courtesy of the University of New South Wales).
Image: Gross pathology of a cross section of a lung from an asthmatic with obstruction of major airways or bronchi (Photo courtesy of the University of New South Wales).
A new urine test could help ensure asthmatic children receive the level of medication they need to manage their illness better and prevent future asthma attacks.

Asthma is a condition that affects the airways and when a person with asthma comes into contact with something that irritates their airways, the muscles around the walls of the airways tighten and become narrower, and the lining of the airways becomes inflamed and starts to swell, causing difficulty in breathing and leading to symptoms of asthma.

Scientists at Queen Mary University of London (UK) in partnership with Jagiellonian University Medical School (Krakow, Poland) reviewed 73 children aged 7 to15 years and found that a urine test can accurately measure levels of inflammation within the urine. Testing was carried out among children with asthma on days when they had no symptoms, and the investigators counted the number of days when they received medical attention or missed school due to asthma symptoms. These urine samples were compared with those of children who did not have asthma.

The teams analyzed levels of prostaglandin metabolites which are chemicals released by immune cells that are activated in asthma and found that one of the protective prostaglandins was greatly reduced in those children who went on to have an asthma attack within three months. The UK has among the highest prevalence rates of asthma symptoms in children worldwide, and there were 25,073 emergency hospital admissions for children in the UK in 2011–2012. That means on average there were 69 per day or one every 21 minutes.

Bernard Higgins, MD, Chairman of the British Thoracic Society Executive Committee, and a consultant lung specialist, said, “Doctors manage a large number of children with asthma throughout the UK and this simple test could help them to prescribe tailored treatment. Most of all this is good news for the well-being of our children with asthma, but attacks of asthma are expensive to treat and if this helps us prevent them it could also save vital NHS resources.” The study was presented at The British Thoracic Society Winter Meeting held December 3–5, 2014, in London (UK).

Related Links:

Queen Mary University of London 
Jagiellonian University Medical School 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.